These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 10855693)

  • 21. Interaction of antiandrogen-androgen receptor complexes with DNA and transcription activation.
    Warriar N; Pagé N; Koutsilieris M; Govindan MV
    J Steroid Biochem Mol Biol; 1993 Dec; 46(6):699-711. PubMed ID: 8274404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The subnuclear three-dimensional image analysis of androgen receptor fused to green fluorescence protein.
    Tomura A; Goto K; Morinaga H; Nomura M; Okabe T; Yanase T; Takayanagi R; Nawata H
    J Biol Chem; 2001 Jul; 276(30):28395-401. PubMed ID: 11369770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Molecular Modeling Study of the Hydroxyflutamide Resistance Mechanism Induced by Androgen Receptor Mutations.
    Liu HL; Zhong HY; Song TQ; Li JZ
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28832499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutant androgen receptors in prostatic tumors distinguish between amino-acid-sequence requirements for transactivation and ligand binding.
    Peterziel H; Culig Z; Stober J; Hobisch A; Radmayr C; Bartsch G; Klocker H; Cato AC
    Int J Cancer; 1995 Nov; 63(4):544-50. PubMed ID: 7591265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone.
    Culig Z; Hobisch A; Cronauer MV; Cato AC; Hittmair A; Radmayr C; Eberle J; Bartsch G; Klocker H
    Mol Endocrinol; 1993 Dec; 7(12):1541-50. PubMed ID: 8145761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of steroidal and non-steroidal antiandrogens on wild-type and mutant androgen receptors.
    Urushibara M; Ishioka J; Hyochi N; Kihara K; Hara S; Singh P; Isaacs JT; Kageyama Y
    Prostate; 2007 Jun; 67(8):799-807. PubMed ID: 17373727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Androgen receptor is targeted to distinct subcellular compartments in response to different therapeutic antiandrogens.
    Whitaker HC; Hanrahan S; Totty N; Gamble SC; Waxman J; Cato AC; Hurst HC; Bevan CL
    Clin Cancer Res; 2004 Nov; 10(21):7392-401. PubMed ID: 15534116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of androgen receptor transactivation by gelsolin: a newly identified androgen receptor coregulator.
    Nishimura K; Ting HJ; Harada Y; Tokizane T; Nonomura N; Kang HY; Chang HC; Yeh S; Miyamoto H; Shin M; Aozasa K; Okuyama A; Chang C
    Cancer Res; 2003 Aug; 63(16):4888-94. PubMed ID: 12941811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic structure-function analysis of androgen receptor Leu701 mutants explains the properties of the prostate cancer mutant L701H.
    van de Wijngaart DJ; Molier M; Lusher SJ; Hersmus R; Jenster G; Trapman J; Dubbink HJ
    J Biol Chem; 2010 Feb; 285(7):5097-105. PubMed ID: 20007693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Androgen receptor antagonist versus agonist activities of the fungicide vinclozolin relative to hydroxyflutamide.
    Wong C; Kelce WR; Sar M; Wilson EM
    J Biol Chem; 1995 Aug; 270(34):19998-20003. PubMed ID: 7650017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system.
    Culig Z; Hoffmann J; Erdel M; Eder IE; Hobisch A; Hittmair A; Bartsch G; Utermann G; Schneider MR; Parczyk K; Klocker H
    Br J Cancer; 1999 Sep; 81(2):242-51. PubMed ID: 10496349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Androgen independence of primary epithelial cultures of the prostate is associated with a down-regulation of androgen receptor gene expression.
    Grant ES; Batchelor KW; Habib FK
    Prostate; 1996 Dec; 29(6):339-49. PubMed ID: 8977630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in the helix 3 region of the androgen receptor abrogate ARA70 promotion of 17beta-estradiol-induced androgen receptor transactivation.
    Thin TH; Kim E; Yeh S; Sampson ER; Chen YT; Collins LL; Basavappa R; Chang C
    J Biol Chem; 2002 Sep; 277(39):36499-508. PubMed ID: 12068007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells.
    Yeh S; Chang C
    Proc Natl Acad Sci U S A; 1996 May; 93(11):5517-21. PubMed ID: 8643607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth of LNCaP human prostate cancer cells is stimulated by estradiol via its own receptor.
    Castagnetta LA; Miceli MD; Sorci CM; Pfeffer U; Farruggio R; Oliveri G; Calabrò M; Carruba G
    Endocrinology; 1995 May; 136(5):2309-19. PubMed ID: 7536668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific recognition of androgens by their nuclear receptor. A structure-function study.
    Poujol N; Wurtz JM; Tahiri B; Lumbroso S; Nicolas JC; Moras D; Sultan C
    J Biol Chem; 2000 Aug; 275(31):24022-31. PubMed ID: 10787411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft model.
    Handratta VD; Vasaitis TS; Njar VC; Gediya LK; Kataria R; Chopra P; Newman D; Farquhar R; Guo Z; Qiu Y; Brodie AM
    J Med Chem; 2005 Apr; 48(8):2972-84. PubMed ID: 15828836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ectopic expression of the amino-terminal peptide of androgen receptor leads to androgen receptor dysfunction and inhibition of androgen receptor-mediated prostate cancer growth.
    Minamiguchi K; Kawada M; Ohba S; Takamoto K; Ishizuka M
    Mol Cell Endocrinol; 2004 Feb; 214(1-2):175-87. PubMed ID: 15062556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of resveratrol and antiandrogen flutamide has synergistic effect on androgen receptor inhibition in prostate cancer cells.
    Kai L; Levenson AS
    Anticancer Res; 2011 Oct; 31(10):3323-30. PubMed ID: 21965742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells.
    Tyagi RK; Lavrovsky Y; Ahn SC; Song CS; Chatterjee B; Roy AK
    Mol Endocrinol; 2000 Aug; 14(8):1162-74. PubMed ID: 10935541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.